All Bacteria articles – Page 2
-
NewsResearchers develop mRNA-based vaccine against a deadly plague-causing bacterium
Researchers have used the platform developed for COVID-19 vaccines to create the world’s first mRNA-based vaccine against the deadly, antibiotic-resistant bacterium behind pneumonic plague.
-
NewsGut microbes key to understanding how exercise boosts cancer immunity
A new study shows how exercise improves cancer outcomes and enhances response to immunotherapy in mice by reshaping the gut microbiome. These benefits are driven by a specific compound called formate, which is produced by gut bacteria in exercised mice.
-
NewsPrairie dogs carry genes linked to surviving plague
A study of the genetic basis of plague immunity in prairie dogs has broad implications for conservation. By comparing whole-genome sequences, the authors identified genetic variants associated with survivorship.
-
NewsResearchers develop superstrong, eco-friendly materials from bacteria
Scientists have developed a scalable approach to engineer bacterial cellulose into high-strength, multifunctional materials. Their biosynthesis technique aligns bacterial cellulose fibers in real-time, resulting in robust biopolymer sheets with exceptional mechanical properties.
-
NewsScientists investigate gut microbiota in elderly patients with acute hepatitis E infection
A new study of the impact of hepatitis E virus infection on the gut microbiota identifies a bacterial species as a potential biomarker for disease outcomes.
-
NewsAI used to create protein that kills E. coli
Scientists have used artificial intelligence (AI) to generate a ready-to-use biological protein that can kill antibiotic resistant bacteria like E. coli.
-
NewsFlightpath Biosciences licenses microbiome-sparing antibiotic developed at Illinois
Flightpath Biosciences, Inc., has licensed a class of antibiotics developed at the University of Illinois Urbana-Champaign. The original antibiotic agent, lolamicin, effectively treated bacterial infections in animal models of disease without wiping out beneficial gut microbes.
-
NewsClinical trials reveal promising alternatives to high-toxicity tuberculosis drug
Research shows two novel antibiotics could spare patients from severe side effects. The drugs sutezolid and delpazolid have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid.
-
NewsProtecting the most vulnerable: ECDC recommendations to address ongoing local transmission of diphtheria
A new ECDC Rapid Risk Assessment highlights how ongoing circulation of diphtheria caused by Corynebacterium diphtheriae may affect some populations who are more vulnerable to infection and issues recommendations to protect those most at risk.
-
NewsChemists boost the efficiency of a key enzyme in bacterial photosynthesis
Chemists have shown that they can greatly enhance a version of the photosynthesis enzyme rubisco found in bacteria from a low-oxygen environment. Using directed evolution, they identified mutations that could boost rubisco’s catalytic efficiency by up to 25 per cent.
-
NewsScientists uncover ‘superfamily’ of bacterial predator proteins
Scientists have identified a new type of protein in bacteria that could change our understanding of how these organisms interact with their environments. It focuses on a protein called PopA, found in the bacterial predator Bdellovibrio bacteriovorus.
-
NewsWhen sunscreen meets plastic: a newly discovered threat to marine ecosystems
The chemical Ethylhexyl Methoxycinnamate - found in sunscreen - could be slowing the degradation of discarded plastic in our seas, and may be helping biofilm bacteria – which have a greater protection from harsh conditions – to thrive.
-
NewsScientists reimagine citrus greening treatment delivery
Texas A&M AgriLife Research is launching a multi-institutional study to develop and evaluate systems that deliver treatments to trees affected by citrus greening disease, also known as Huanglongbing.
-
NewsEstrela brings microbial research to Texas A&M AgriLife Department of Nutrition
Sylvie Estrela, Ph.D., has joined the Texas A&M College of Agriculture and Life Sciences Department of Nutrition as an assistant professor. Estrela’s research focuses on microbial interactions, specifically, the way nutrients can impact bacterial communities.
-
NewsMediterranean bacteria may harbor new mosquito solution
Researchers recently identified bacteria in Crete producing metabolites that quickly kill mosquito larvae in lab tests. The compounds might be useful for the development of new biopesticides, though developing the right formulations and delivery method remains a challenge.
-
NewsStudy reveals beneficial microbes that can sustain yields in unfertilized fields
Naturally occurring bacteria in rice roots could help reduce the reliance on chemical fertilizers for rice cultivation, paving the way for sustainable agriculture.
-
NewsNew breakthrough uncovers how to kill ‘zombie’ TB cells resistant to antibiotics
Researchers exposed a library of over 500,000 genetically modified tuberculosis bacteria to two commonly used antibiotics. By analysing the survivors, they pinpointed genes whose disruption significantly reduced the number of surviving persisters.
-
NewsMultiresistant intestinal bacteria: Displacement through food competition
Researchers made use of food competition to figure out how potentially dangerous multi-resistant bacteria could be effectively removed from the gut before reaching the bloodstream and causing serious problems.
-
NewsStudy reveals engineered bacterial vesicles to combat antimicrobial resistance
Researchers studying extracellular vesicles (EVs)-membrane-bound nanoparticles released by cells that transport biologically active molecules like proteins or nucleic acids have engineered EVs derived from lactic acid bacteria to carry pathogen-specific endolysins on their surface.
-
NewsImmune responses to friendly skin microbiota could pave way for novel vaccination responses
For her research into how the immune system responds to the beneficial skin microbiome, Djenet Bousbaine is the winner of the 2025 NOSTER & Science Microbiome Prize. Her work reveals a surprisingly sophisticated immune response that could be harnessed for the development of innovative, needle-free vaccination strategies.